New research shows how second-degree burns cause hard-to-treat chronic pain, and this understanding may be key to treating these complications, common in war veterans.
Residents of rural, sparsely-populated "frontier counties" in the Western U.S. face higher incidents of skin cancer and related mortality rates.
Boston, MA -- Chemical compounds found in skin creams and other personal care products can cause an allergic reaction in the skin, a common condition known as allergic contact dermatitis (ACD).
A study from Washington University School of Medicine in St. Louis may help explain why previous attempts to develop a staph vaccine have failed, while also suggesting a new approach to vaccine design that focuses on activating an untapped set of immune cells, as well as immunizing against staph within the first few days after birth.
Drs. Jean-Pierre Galliani and Naomi Johansen receive American Academy of Dermatology “Patient Care Hero” award
American Academy of Dermatology recognizes Dr. Loretta Davis with national “Patient Care Hero” award
The University of Pennsylvania’s Dr. Cory Simpson receives national “Patient Care Hero” honor from the American Academy of Dermatology
Researchers at Children’s Medical Center Research Institute at UT Southwestern (CRI) have uncovered why certain melanoma cells are more likely to spread through the body.
Indiana University researchers have discovered that a chemical compound found in essential oils improves the healing process in mice when it is topically applied to a skin wound.
Researchers reporting in ACS Nano have devised a blood test that quickly and sensitively diagnoses the disease at early stages.
Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Since acne-prone skin is sensitive, people with acne may find that certain makeup products, such as foundations and concealers, worsen acne or cause new breakouts. As the holidays approach and people start preparing for parties and other festivities, dermatologists from the American Academy of Dermatology say it’s okay for acne patients to wear makeup. The key, they say, is to select cosmetics that don’t cause acne and establish a skin care routine that works for your skin type.
A new clinical guideline from ASTRO provides recommendations on the use of radiation therapy to treat patients diagnosed with the most common types of skin cancers. The guideline details when radiation treatments are appropriate as stand-alone therapy or following surgery for BCC and cSCC, and it suggests dosing and fractionation.
If you are thinking of buying a skin rejuvenation device as a holiday gift, think again.
Dr. Amit G. Pandya receives national honor from the American Academy of Dermatology
Eastern Virginia Medical School Dermatology’s Dr. Abby Van Voorhees receives national honor from the American Academy of Dermatology
Drs. Steven Daveluy and Benjamin Workman receive national honor from the American Academy of Dermatology
Recommendations suggest that opioids are not routinely needed for pain management after most dermatologic procedures, and minimizing their use helps improve patient care and safety
Researchers from Penn compare a lymphoma-dose regimen of rituximab to a rheumatoid arthritis regimen for the treatment of pemphigus.
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found that the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis. Additionally, they found that pustular psoriasis is associated with arthritis onset two years earlier than the intercept interval; and there is an increased delay for nail involvement, plaque psoriasis or family history of psoriasis from psoriasis to arthritis by approximately two years for each characteristic.(Abstract #2854).
New research findings presented at the 2019 ACR/ARP Annual Meeting found a strong association between changes in atmospheric and environmental variables 10 days before a clinic visit and organ-specific lupus flares in patients with systemic lupus erythematosus (Abstract #695).
New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor (TNFi) inhibitors first (Abstract# 2911).
Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases. However, in some patients they can trigger or exacerbate psoriasis, an inflammatory skin disease.
Dermatologists say psoriasis may affect a child’s quality of life as much as diabetes, epilepsy and atopic dermatitis
Elizabeth K. Usher, MBA, has been named executive director/chief executive officer of the American Academy of Dermatology and American Academy of Dermatology Association (AAD/A). Usher comes to the Academy from the College of American Pathologists (CAP), most recently holding the position of chief market and customer officer.
Immunotherapy has become a standard treatment approach for several types of cancer, including melanoma. However, tumors can escape immune cell detection even with the use of immunotherapies. In a new study published in Cancer Immunology Research, Moffitt Cancer Center researchers, in collaboration with the University of Miami’s Miller School of Medicine, describe a cellular mechanism that controls tumor cell recognition by immune cells.
Researchers at Rensselaer Polytechnic Institute have developed a way to 3D print living skin, complete with blood vessels. The advancement, published online today in Tissue Engineering Part A, is a significant step toward creating grafts that are more like the skin our bodies produce naturally.
The enhanced site showcases AAD.org’s best-in-class public content and reinforces its status as one of HealthWeb.org’s ‘Highly Recommended’ health sites
Board-certified dermatologists are experts when it comes to the skin, hair and nails, diagnosing and treating more than 3,000 diseases and conditions, including skin cancer, acne, psoriasis and eczema. They also help patients address their cosmetic concerns, such as tattoo removal, scarring, and aging skin. But do you ever wonder what skin care tips dermatologists use themselves to maintain healthy skin? In recognition of National Healthy Skin Month in November, dermatologists from the American Academy of Dermatology are sharing six skin care tips they recommend to all of their patients—and actually use themselves.
Dental health and diet may have an impact on the development and severity of psoriasis, according to a study by dermatologists at The Ohio State University Wexner Medical Center. Psoriasis is a skin disease that causes thick, itchy patches of red skin with silvery scales and affects more than 8 million Americans.
The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage. Results of the study, which was conducted by the Eastern Cooperative Oncology Group and funded by the National Cancer Institute, were published Friday, Oct. 25, in the Journal of Clinical Oncology.
Columbia University researchers have captured new images of a temperature-sensing molecule in its open, intermediate, and closed states.
A molecule that protects plants from overexposure to harmful sunlight thanks to its flamenco-style twist could form the basis for a new longer-lasting sunscreen, chemists at the University of Warwick have found, in collaboration with colleagues in France and Spain.
A new paper published in the October 17 2019 issue of Clinical Infectious Diseases reiterates the need to stop the infection and defines a strategy for developing effective vaccines.
In a study using non-invasive tape strips in young children with eczema (or atopic dermatitis), researchers found many molecular signs of immune dysfunction and skin changes that relate to disease activity. These signs (or biomarkers) were present even before eczema was visible and can be used to track disease activity over time. With more research, these biomarkers also may help predict response to medicine and development of conditions associated with eczema, such as asthma, other allergies, infections and even attention deficit hyperactivity disorder (ADHD). Findings were published in JAMA Dermatology.
This fall, a group of skin cancer advocates and their families and friends in both Chicago and Phoenix hiked three miles to say “Skin Cancer, Take a Hike!” Together, they raised nearly $40,000 for SPOT Skin Cancer™ benefiting the American Academy of Dermatology’s skin cancer prevention and detection programs, including free skin cancer screenings, sunscreen dispensers, and permanent shade structures in outdoor spaces where children learn and play.
Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret. Columbia biomedical engineers have developed a rapid microfluidic test that can detect Lyme disease with similar performance as the STT in a much shorter time—15 minutes.
A new study led by UCLA researchers, have found that obtaining a second opinion from pathologists who are board certified or have fellowship training in dermatopathology can help improve the accuracy and reliability of diagnosing melanoma, one of the deadliest and most aggressive forms of skin cancer.
Atopic dermatitis (also known as eczema) is a common skin condition in babies. It affects up to 25% of children, and an estimated 60% of people with eczema develop it during their first year of life. While there is no cure, dermatologists from the American Academy of Dermatology say most cases can be controlled with a customized skin care plan, which may include moisturizers, prescription medications and strategies to eliminate triggers.
May also help predict therapeutic responses
To conduct preclinical testing of locally-acting topical dermal and ophthalmic drug product formulations
In a new study published in EBioMedicine, researchers with Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence reveal that differences at the single-cell level can predict responses to initial BRAF inhibitor therapy, and that leveraging these differences may improve patient outcomes.
Head and neck melanoma among pediatric, adolescent and young adult populations in the United States and Canada increased by 51.1% from 1995 to 2014, per research from Saint Louis University.
Results suggest that the combined treatment can lower the effective chemotherapy dosage, reduce side effects, improve tumor cell apoptosis, and reduce tumor cell migration.
October is National Breast Cancer Awareness Month, a great time to spread the word about the importance breast cancer screening and being alert to breast changes. After skin cancer, breast cancer is the most common type of cancer diagnosed in women in the U.S.
Millions of people with severe burns or diabetic skin ulcers could benefit from an experimental enhancement to a next-generation covering that is already healing difficult wounds.
It’s often difficult to manage patients with lichen planus, but new research identifies a target that existing medications are able to address.
Using a small noncoding RNA, microRNA 211, and tools that track the stability and decay of the protein-coding and noncoding RNAs in lab-grown melanoma cells, a team led by a Johns Hopkins Kimmel Cancer Center researcher identified highly unstable RNA molecules in human melanomas, including a novel miR-211 target gene DUSP3.
A new study from a Binghamton University research team uses the topography of human skin as a model not for preventing cracks but for directing them in the best way possible to avoid critical components and make repairs easy.
Skin cancer is the most common cancer in the United States, affecting one in five Americans during their lifetime. To help raise awareness of skin cancer prevention and detection, the American Academy of Dermatology will host Skin Cancer, Take a Hike!™ – Chicago on Sat., Sept. 28 in Elk Grove Village. The scenic, four-mile walk at Busse Woods—part of the AAD’s SPOT Skin Cancer™ campaign to create a world without skin cancer—will benefit skin cancer prevention and detection programs, including free skin cancer screenings, sunscreen dispensers, and permanent shade structures where children learn and play.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right